Oncology Data Advisor
The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:22
- Mas informaciones
Informações:
Sinopsis
In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Luis Valente, CEO and Co-Founder of iLoF, a digital health company pioneering a breakthrough AI platform to accelerate the future of personalized drug discovery and development.
